172 related articles for article (PubMed ID: 23772048)
1. Regulation of human class I alcohol dehydrogenases by bile acids.
Langhi C; Pedraz-Cuesta E; Haro D; Marrero PF; Rodríguez JC
J Lipid Res; 2013 Sep; 54(9):2475-84. PubMed ID: 23772048
[TBL] [Abstract][Full Text] [Related]
2. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
4. Human kininogen gene is transactivated by the farnesoid X receptor.
Zhao A; Lew JL; Huang L; Yu J; Zhang T; Hrywna Y; Thompson JR; de Pedro N; Blevins RA; Peláez F; Wright SD; Cui J
J Biol Chem; 2003 Aug; 278(31):28765-70. PubMed ID: 12761213
[TBL] [Abstract][Full Text] [Related]
5. Diacylglycerol kinase θ couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes.
Cai K; Sewer MB
Biochem J; 2013 Sep; 454(2):267-74. PubMed ID: 23767959
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
[TBL] [Abstract][Full Text] [Related]
7. GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression.
Zhang S; Pan X; Jeong H
Drug Metab Dispos; 2015 May; 43(5):743-8. PubMed ID: 25725071
[TBL] [Abstract][Full Text] [Related]
8. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor.
Jung D; Podvinec M; Meyer UA; Mangelsdorf DJ; Fried M; Meier PJ; Kullak-Ublick GA
Gastroenterology; 2002 Jun; 122(7):1954-66. PubMed ID: 12055601
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
10. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
[TBL] [Abstract][Full Text] [Related]
11. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
[TBL] [Abstract][Full Text] [Related]
12. Farnesoid X receptor regulates bile acid-amino acid conjugation.
Pircher PC; Kitto JL; Petrowski ML; Tangirala RK; Bischoff ED; Schulman IG; Westin SK
J Biol Chem; 2003 Jul; 278(30):27703-11. PubMed ID: 12754200
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
[TBL] [Abstract][Full Text] [Related]
14. Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1.
Hoeke MO; Heegsma J; Hoekstra M; Moshage H; Faber KN
PLoS One; 2014; 9(2):e88011. PubMed ID: 24498423
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
[TBL] [Abstract][Full Text] [Related]
16. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
[TBL] [Abstract][Full Text] [Related]
17. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.
Barbier O; Torra IP; Sirvent A; Claudel T; Blanquart C; Duran-Sandoval D; Kuipers F; Kosykh V; Fruchart JC; Staels B
Gastroenterology; 2003 Jun; 124(7):1926-40. PubMed ID: 12806625
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor represses hepatic lipase gene expression.
Sirvent A; Verhoeven AJ; Jansen H; Kosykh V; Darteil RJ; Hum DW; Fruchart JC; Staels B
J Lipid Res; 2004 Nov; 45(11):2110-5. PubMed ID: 15342685
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S
FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells.
Lu D; Wang S; Xie Q; Guo L; Wu B
Mol Pharm; 2017 Sep; 14(9):2899-2907. PubMed ID: 28267333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]